Insiders · RSLS

RSLS insider transactions

ReShape Lifesciences Inc. (RSLS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for RSLS

• 620d
  Chief Financial Officer Stankovich Thomas sold $39 worth of shares (172 units at $0.23), decreasing direct ownership by 0.75% to 22,777 units (SEC Form 4)

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 830d
  New insider Schneid Yair claimed ownership of 2,461,000 shares (SEC Form 3)

  3 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 899d
  Stankovich Thomas sold $386 worth of shares (435 units at $0.89), decreasing direct ownership by 2% to 22,949 units (SEC Form 4)

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1011d
  SEC Form 4 filed by Stankovich Thomas

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1024d
  SEC Form 4 filed by Stankovich Thomas

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1145d
  SEC Form 4: Stankovich Thomas sold $3,708 worth of shares (418 units at $8.87), decreasing direct ownership by 6% to 6,091 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1222d
  SEC Form 4: Stankovich Thomas was granted 364,756 shares and sold $62,938 worth of shares (372,113 units at $0.17), decreasing direct ownership by 2% to 325,404 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1262d
  SEC Form 4: Stankovich Thomas sold $2,287 worth of shares (8,393 units at $0.27), decreasing direct ownership by 2% to 332,761 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1297d
  SEC Form 4: Stankovich Thomas sold $2,329 worth of shares (8,293 units at $0.28), decreasing direct ownership by 2% to 338,670 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1321d
  SEC Form 4: Stankovich Thomas sold $1,883 worth of shares (4,828 units at $0.39), decreasing direct ownership by 1% to 346,963 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1338d
  SEC Form 3: New insider Hickey Paul F. claimed no ownership of stock in the company

  3 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1353d
  SEC Form 4: Stankovich Thomas sold $2,222 worth of shares (4,728 units at $0.47), decreasing direct ownership by 1% to 351,791 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1353d
  SEC Form 4: Bandy Barton P. sold $5,487 worth of shares (11,674 units at $0.47), decreasing direct ownership by 1% to 773,098 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1389d
  SEC Form 4: Stankovich Thomas sold $2,546 worth of shares (4,630 units at $0.55), decreasing direct ownership by 1% to 356,519 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1389d
  SEC Form 4: Bandy Barton P. sold $6,293 worth of shares (11,442 units at $0.55), decreasing direct ownership by 1% to 784,772 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1419d
  SEC Form 4: Bandy Barton P. sold $10,771 worth of shares (11,309 units at $0.95), decreasing direct ownership by 1% to 796,214 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1419d
  SEC Form 4: Stankovich Thomas sold $4,299 worth of shares (4,478 units at $0.96), decreasing direct ownership by 1% to 361,149 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1424d
  SEC Form 4: Stankovich Thomas bought $18,422 worth of shares (20,000 units at $0.92), increasing direct ownership by 6% to 365,627 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1444d
  SEC Form 4: Bandy Barton P. sold $8,791 worth of shares (11,417 units at $0.77), decreasing direct ownership by 1% to 807,523 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1444d
  SEC Form 4: Stankovich Thomas sold $3,487 worth of shares (4,529 units at $0.77), decreasing direct ownership by 1% to 345,627 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1478d
  SEC Form 4: Stankovich Thomas sold $5,693 worth of shares (5,038 units at $1.13), decreasing direct ownership by 1% to 350,156 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1478d
  SEC Form 4: Bandy Barton P. sold $12,501 worth of shares (11,063 units at $1.13), decreasing direct ownership by 1% to 818,940 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1515d
  SEC Form 4: Stankovich Thomas sold $3,877 worth of shares (3,658 units at $1.06), decreasing direct ownership by 1% to 355,194 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1515d
  SEC Form 4: Bandy Barton P. sold $6,930 worth of shares (6,538 units at $1.06), decreasing direct ownership by 0.78% to 830,003 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1543d
  SEC Form 4: Bandy Barton P. sold $10,155 worth of shares (8,324 units at $1.22), decreasing direct ownership by 0.99% to 836,541 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1543d
  SEC Form 4: Stankovich Thomas sold $4,494 worth of shares (3,684 units at $1.22), decreasing direct ownership by 1% to 358,852 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1548d
  SEC Form 4: Bandy Barton P. sold $12,798 worth of shares (7,150 units at $1.79), decreasing direct ownership by 0.84% to 844,865 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1548d
  SEC Form 4: Stankovich Thomas sold $5,644 worth of shares (3,171 units at $1.78), decreasing direct ownership by 0.87% to 362,536 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1598d
  SEC Form 4: Bandy Barton P. sold $24,571 worth of shares (13,427 units at $1.83), decreasing direct ownership by 2% to 852,015 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1598d
  SEC Form 4: Stankovich Thomas sold $7,863 worth of shares (4,304 units at $1.83), decreasing direct ownership by 1% to 365,707 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1619d
  SEC Form 4: Stankovich Thomas bought $40,400 worth of shares (20,000 units at $2.02), increasing direct ownership by 6% to 370,011 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1621d
  SEC Form 4: Bandy Barton P. sold $36,328 worth of shares (13,505 units at $2.69), decreasing direct ownership by 2% to 865,442 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1621d
  SEC Form 4: Stankovich Thomas sold $11,621 worth of shares (4,320 units at $2.69), decreasing direct ownership by 1% to 350,011 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1656d
  SEC Form 4: Stankovich Thomas sold $10,102 worth of shares (3,660 units at $2.76), decreasing direct ownership by 1% to 354,331 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1656d
  SEC Form 4: Bandy Barton P. sold $34,805 worth of shares (12,565 units at $2.77), decreasing direct ownership by 1% to 878,947 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1681d
  SEC Form 4: Bandy Barton P. was granted 1,186,006 units of Common Stock and sold $851,088 worth of Common Stock (294,494 units at $2.89)

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1681d
  SEC Form 4: Stankovich Thomas was granted 372,744 units of Common Stock and sold $139,778 worth of Common Stock (48,366 units at $2.89), increasing direct ownership by 965% to 357,991 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1681d
  SEC Form 4: Gladney Dan W was granted 483,922 units of Common Stock and sold $598,000 worth of Common Stock (200,000 units at $2.99)

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1681d
  SEC Form 4: Blackford Gary was granted 253,429 units of Common Stock

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1681d
  SEC Form 4: Minocherhomjee Arda Phd was granted 253,429 units of Common Stock

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1681d
  SEC Form 4: Mcdougal Lori Courtney was granted 253,429 units of Common Stock

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1698d
  SEC Form 4: Stankovich Thomas bought $51,435 worth of Common Stock (15,000 units at $3.43), increasing direct ownership by 85% to 32,613 units

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)
• 1706d
  SEC Form 4 filed by ReShape Lifesciences Inc.

  4 - ReShape Lifesciences Inc. (0001427570) (Issuer)